Alberto Esquenazi, MD; Albert Einstein Medical Center
Dr. Esquenazi is Director of the Gait and Motion Analysis Laboratory, Clinical Director of the Regional Amputee Center and Chief of the Prosthetic and Orthotic Clinic. He is also Codirector of the Institute for Mobility Evaluation and Treatment and Post-Polio Program at Albert Einstein Medical Center.
Dr. Esquenazi is a member of the Task Force on Medical Rehabilitation Research for the U.S. Department of Health and Human Services. He teaches at Temple University and Drexel University. He serves as director of the Annual Inter-City Gait and Orthotics course sponsored by Temple University. Dr. Esquenazi received his medical degree at the National Autonomous University of Mexico School of Medicine in Mexico City. He is board-certified in physical medicine and rehabilitation and is a fellow of the American Academy of Cerebral Palsy and Developmental Medicine. He also is a member of the American Society of Biomechanics, the North American Society Gait and Clinical Movement Analysis and the International Society of Prosthetics and Orthotics.
Dr. Esquenazi has been recognized by Philadelphia Magazine as one of the region's "Top Docs."
Jean-Michel Gracies, MD; Mt. Sinai School of Medicine, N.Y.
Dr. Gracies completed his internships in intensive care, neurorehabilitation, neurology, and stroke pathology at Hôpitaux de Paris, France and received his medical degree and doctorate in neurophysiology from University of Paris VI. He served a postdoctoral fellowship in pathophysiology and therapy of spasticity at Prince of Wales Medical Research Institute in Sydney, Australia, and a fellowship in neurology-movement disorders at Mount Sinai Medical Center in New York City.
Dr. Gracies is a member of the International Movement Disorders Society. Beside his research activity in Parkinson's disease, he is principal investigator for several current research projects involving the treatment of spasticity, focusing on techniques of injection of botulinum toxin and on improved methods of spasticity assessment. He is currently the National Co-chair in the Comed/Allergan Advances in Spasticity Management Continual Medical Education program.
Dr. Gracies has written more than 50 articles, book chapters, theses, reviews, and abstracts and has lectured nationally and internationally. He is member of the Editorial Board of Journal of Neural Transmission and is an ad hoc reviewer for Stroke, Movement Disorders, Muscle and Nerve, Clinical Neuropharmacology, and Archives of Physical Medicine and Rehabilitation.
Cindy Ivanhoe, MD; Baylor College of Medicine, TX
Cindy Ivanhoe, MD is the Director of the Brain Injury and Stroke Program at the Institute for Rehabilitation and Research (TIRR) at the Texas Medical Center. She is also the Chairperson of the Spasticity Committee at TIRR. She is an Assistant Professor of Physical Medicine and Rehabilitation at the Baylor College of Medicine and the University of Texas Health Science Center in Houston.
Dr. Ivanhoe earned her BA at Sarah Lawrence College in New York and her MD from the Autonomous University of Guadalajara. She completed the Fifth Pathway program at New York Medical College. She completed her residency at the University of Illinois at Chicago and her fellowship at the Baylor College of Medicine. She is board-certified in Physical Medicine and Rehabilitation.
Dr. Ivanhoe is the youngest recipient of the Lifetime Achievement Award by the Brain Injury Association of Texas (2002).
Dr. Ivanhoe serves on the Spasticity and Movement Disorders Advisory Board to the national office of Easter Seals.
Nathaniel H. Mayer, MD; Temple University School of Medicine
Dr. Mayer is Director of the Drucker Brain Injury Center at MossRehab. He is also Director of the Motor Control Analysis Laboratory and is one of the Directors of the Institute for Mobility Evaluation and Treatment, a combined program of MossRehab and Albert Einstein Medical Center. He also serves as Professor of Physical Medicine and Rehabilitation at Temple University School of Medicine.
He is a pioneer in the rehabilitation of persons with traumatic brain injury. He is nationally known as an advocate for a functional approach to rehabilitation. In 1993, he received the Sheldon Berrol Clinical Services Award from the National Head Injury Foundation for outstanding contributions to improving quality care, professional training and education in the field of head injury rehabilitation.
Dr. Mayer is a graduate of Columbia College. He received his medical degree from Albert Einstein College of Medicine in New York. He received a two-year fellowship from the National Institute of General Medical Science to study biomedical engineering at Drexel University. He is certified by the American Board of Physical Medicine and is licensed to practice in Pennsylvania and New Jersey.
Dr. Mayer has been recognized by Philadelphia Magazine as one of the region's "Top Docs."
David Simpson, MD; Mt. Sinai School of Medicine, N.Y
David M. Simpson, MD, is a Professor of Neurology at the Mount Sinai Medical Center in New York. He is also the Director of the Clinical Neurophysiology Laboratories at the Mount Sinai Hospital. Dr. Simpson received his MD from the State University of New York at Buffalo. He then trained in internal medicine at Case Western Reserve University, and neurology at Cornell Medical Center. He completed a fellowship in clinical neurophysiology at the Massachusetts General Hospital and Harvard Medical School.
Dr. Simpson's clinical and research interests have been focused in two major areas. The first is the neurologic complications of HIV infection and AIDS. Since pioneering this field of research at its inception in the early 1980s, Dr. Simpson has been recognized internationally for his work, and has lectured and had visiting professorships throughout the world. Dr. Simpson has held leadership positions in several national and international AIDS research collaborative groups. He has served as Chairman of the Neurology Subcommittee of the AIDS Clinical Trials Group (ACTG) and on the Executive Steering Committee of the Neurologic AIDS Research Consortium (NARC). Both of these groups are funded by the National Institutes of Health.
Dr. Simpson is the Director of the Neuro-AIDS Program at Mount Sinai Hospital. The mission of this program is delivery of state-of-the-art clinical care, research, and education, in matters pertaining to the effects of HIV on the nervous system. Dr. Simpson has authored more than 86 original articles, 48 book chapters and reviews, and 68 abstracts. He has received numerous research grants from the National Institutes of Health and the pharmaceutical industry.
Dr. Simpson's second major area of research concerns the use of botulinum toxin in the treatment of spasticity. Dr. Simpson was a lead investigator and primary author of one of the first randomized, placebo-controlled clinical trials demonstrating the efficacy of botulinum toxin in the treatment of upper-extremity spasticity following stroke. His seminal investigations in this field continue, with a focus on the improvement of botulinum toxin injection technique, using anatomical and physiological studies. Dr. Simpson maintains an active clinical and electromyography practice at Mount Sinai Hospital.
|
